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ABSTRACT
Androgen receptor-positive LNCaP cells were stably transfected
with a rat glucocorticoid receptor (GR) expression plasmid. Ligand-
binding studies in the generated cell lines revealed high-affinity bind-
ing of the cognate ligands to their receptors. Transfection experiments
with the newly derived cell lines showed that, like androgen receptor,
GR can induce activity of a prostate-specific antigen promoter frag-
ment linked to the luciferase gene. Similarly, dexamethasone can
stimulate expression of endogenous prostate-specific antigen mes-
senger RNA. Cell proliferation could be induced by R1881. In contrast,
dexamethasone treatment of the GR-positive sublines had no stim-
ulatory effect on cell growth. Using the differential display technique,
a so far unknown complementary DNA fragment, designated 21.1,
specifically induced by androgens and not by glucocorticoids, has been
identified. In conclusion, the newly generated cell lines, together with
the parental LNCaP cell line, form an attractive system with which
to study the mechanism of specificity of steroid hormone regulation
of gene expression. (Endocrinology 138: 5293–5300, 1997)
STEROID HORMONES affect many biological activities ofthe cell by modulating gene activity via interaction with
specific nuclear receptors (1–3). Upon ligand binding, steroid
receptors interact with specific DNA sequences and regulate
the transcriptional activity of target genes (1–4). The glu-
cocorticoid receptor (GR), mineralocorticoid receptor (MR),
progesterone receptor (PR), and androgen receptor (AR)
bind with high affinity to a DNA element composed of an
inverted repeat, separated by a 3-bp spacer sequence. The
consensus high- affinity binding site for GR, MR, PR, and AR
(HRE: hormone response element) is identical (5–8). Al-
though there are genes that can be regulated by more than
one specific steroid hormone receptor, the biological function
of the different receptors is quite distinct. This presents the
problem of specific gene activation in the event that multiple
receptors, which recognize the same DNA-binding site, are
present in one and the same cell. Several mutually nonex-
clusive mechanisms to explain specificity, including subtle
differences in receptor-DNA interaction, specificity of the
interaction of the receptor with other proteins, receptor lev-
els, and ligand availability, have been proposed (1–3).
LNCaP is an androgen-sensitive human prostatic carci-
noma cell line (9) that expresses AR, but lacks GR and PR (10,
11). It was shown previously that growth of LNCaP cells,
maintained in steroid-depleted culture medium, is stimu-
lated by the addition of androgens (11). The synthetic an-
drogen R1881, at a concentration of 10210 m, increases the
growth rate; a higher R1881 concentration is suboptimal to
cell proliferation and might even have no stimulatory effect.
Androgen treatment of LNCaP cells increases the messenger
RNA (mRNA) level and production and secretion of pros-
tate-specific antigen (PSA) (12–14).
In the present study we describe the generation and initial
characterization of LNCaP sublines, in which the GR was
stably expressed. In this way a system was established for
comparison of AR and GR molecular and biological func-
tions in a well defined cell line expressing comparable
amounts of both receptors.
Materials and Methods
Cell culture
LNCaP prostate cells were cultured in RPMI 1640 supplemented with
5% FCS (Boehringer, Mannheim, Germany) and antibiotics. For trans-
fection, cells were grown in DMEM supplemented with 5% FCS.
Plasmids and probes
The rat GR expression plasmid PSTC-GR(3–795) and the selection
plasmid pSV2Neo were described previously (15, 16). PSA-61-LUC was
generated by integration of a 6-kb HindIII-HindIII (26000/112) frag-
ment of the PSA promoter in the multiple cloning site of pLUC (17).
Southern and Northern blots were hybridized with a rat (r) GR com-
plementary DNA (cDNA) fragment (nucleotide 2256–2543) obtained by
PCR amplification with primers: 59-GAGTCTCACAAGACACTTCG-39
and 59-GAAACATCCATGAGTACTG-39 and plasmid PSTC-GR(3–795)
as template using standard methods. Northern blots were hybridized
with the 320-bp EcoRI-ClaI fragment of PSA75 cDNA (18), and a 1.2-kb
PstI-PstI hamster actin cDNA fragment as a control.
Transfections
Stable transfection. LNCaP cells were transfected according to the calcium
phosphate precipitation method essentially as described (19), using 3 3
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106 cells per 10-cm dish, 10 mg PSTC-GR(3–795) and 2 mg pSV2Neo. After
overnight incubation with the precipitate, the culture medium was re-
placed by PBS, containing 15% glycerol (incubation for 90 sec at room
temperature). Subsequently, transfected cells were incubated in culture
medium for 24 h. Next, culture medium was replaced by maintenance
medium supplemented with G418 (GIBCO BRL, Grand Island, NY) at
a concentration of 1.2 mg/ml. The resulting G418-resistant clones were
seeded into 96-well plates and selected for GR expression by immuno-
histochemistry (see below).
Transient transfection. The GR-positive clones LNCaP-1B7 and LNCaP-
1F5 and the parental LNCaP cells were transiently transfected according
to the calcium phosphate method using 1 3 106 cells per 25-cm2 flask and
5 mg PSA-61-LUC. After overnight incubation with the precipitate, the
culture medium was removed and cells were shocked in PBS, containing
15% glycerol (90 sec at room temperature). Subsequently, transfected
cells were incubated in culture medium in the absence or presence of 10
nm of the synthetic glucocorticoid dexamethasone (Dex) (Sigma, St.
Louis, MO) or 1 nm R1881 (DuPont NEN, Boston, MA) for 24 h. Trans-
fections were performed three times in duplicate, using two indepen-
dent plasmid isolates. Luciferase activities were corrected for variations
in protein concentrations in 100-ml cell extract samples.
Luciferase assay
Cells were washed once in PBS and subsequently lysed in 300 ml lysis
buffer (25 mm Tris-phosphate, pH 7.8, 8 mm MgCl2, 1 mm dithiothreitol,
1% Triton X-100, 15% glycerol). Next, 100 ml 0.1 mm luciferin (Sigma)/
0.25 mm ATP were added to 100 ml extract, and luciferase activity was
measured in a LUMAC 2500 M Biocounter (LUMAC, Landgraaf, The
Netherlands). After a delay of 2 sec (according to the supplier), the light
emission during 5 sec was recorded.
Immunohistochemistry
Immunostaining for GR was performed with the monoclonal anti-GR
(rat) antibody Mab 7 (20). Cells were seeded at a density of 3 3 105 cells
per well on sterile micro slides in four-well tissue culture plates (Heraeus
Instruments, Hanau, Germany) in maintenance medium supplemented
with G418 and cultured until 50–60% confluence. Next, 10 nm Dex was
added, and the incubation was continued for 24 h. Cells were washed
in PBS and fixed for 10 min in 10% phosphate-buffered formalin (pH 7.4).
Subsequently, the slides were rinsed in PBS (pH 7.4), and attached cells
were made permeable in methanol (220 C, 5 min) and acetone (220 C,
2 min). After rehydration in PBS, the slides were incubated in 5% non-
immune rabbit serum in PBS followed by overnight incubation in 1:1000
diluted monoclonal antibody Mab7 at 4 C. Excess antibody was re-
moved, and rGR immunoreactivity was visualized using rabbit anti-
mouse Ig (DAKO, Glostrup, Denmark) as secondary antibody and
mouse monoclonal peroxidase antiperoxidase complexes (DAKO) as
third-step reagent. After three PBS washes, the slides were incubated
with diaminobenzidine. The reaction was stopped in water. Cells were
counterstained with Mayers hematoxylin.
Southern and Northern blot analysis
Total cellular DNA of LNCaP- and GR-positive sublines LNCaP-1F5
and LNCaP-1B7 was isolated using standard procedures (21). Ten mi-
crograms of DNA were digested with EcoRI for 16 h, electrophoresed on
0.8% agarose gel, and transferred to a Hybond N1 membrane (Amer-
sham, Cardiff, UK). Filters were hybridized at high stringency with
random primed 32P-labeled probes. Both DNA transfer and filter hy-
bridization were carried out according to the protocol of the
manufacturer.
Isolation of total cellular RNA from the different cell lines was carried
out by the guanidinium thiocyanate method (22). Glyoxal denatured
RNA (10 mg/lane) was separated by electrophoresis on a 1% agarose gel
and transferred to a nylon membrane (Gene Screen, DuPont NEN,
Boston, MA). The blot was hybridized with random primed 32P-labeled
rGR, PSA, or actin cDNA probes in 50% formamide at 42 C, using
standard conditions.
Radioligand binding assay
Cells were cultured in maintenance medium until 50–60% conflu-
ence. To deplete for steroids, cell culturing was continued in RPMI 1640
supplemented with dextran-charcoal-stripped (dcc) serum for 48 h.
[3H]-R1881 (87 Ci/mmol) and unlabeled R1881 (methyl-trienolone)
were purchased from DuPont NEN. [3H]-Dex (94 Ci/mmol) was ob-
tained from Amersham. For radioligand-binding analysis, cells were
rinsed in PBS and harvested as a single-cell suspension by trypsiniza-
tion. Cells were washed four times, counted, and resuspended in ice-
cold PBS. To measure the cellular AR and GR content and ligand affinity
of both receptors, cells were incubated with serial [3H]R1881 dilutions
(0.125–16 nm, in the absence and presence of a 100-fold molar excess of
unlabeled R1881) or [3H]Dex dilutions (0.5–32 nm, in the absence and
presence of a 100-fold molar excess of unlabeled Dex) for 90 min at room
temperature. Free steroid was removed by extensive washing of the cells
in ice-cold PBS. Radioactivity was measured in a scintillation counter.
Specific binding of [3H]R1881 and [3H]Dex was calculated by subtraction
of nonspecifically bound radioactivity from total bound radioactivity
and used for Scatchard analysis with the radioligand-binding analysis
program Ebda/Ligand by G. A. Pherson from Elsevier-BIOSOFT (Cam-
bridge, UK). All assays were performed in triplicate.
Cell growth studies
Cells were trypsinized, seeded in RPMI medium containing 5% FCS
in 25-cm2 tissue culture flasks at a density of 5 3 104 cells, and cultured
for 3 days. Subsequently, medium was replaced by medium containing
5% dcc serum, and the incubation was continued for an additional 3
days. At this time point (t 5 0), medium was replaced by RPMI medium
containing 5% dcc serum and indicated hormones at different concen-
trations. R1881 was added to final concentrations of 10211, 10210, and
1029 m; Dex was added to final concentrations of 10210, 1029, and 1028
m, respectively. Control cultures without steroids were supplemented
with 0.1% (vol/vol) ethanol. At day 4, medium was renewed. At day 8,
cells were washed in PBS and trypsinized, and the cell number in each
tissue culture flask was determined using a Bu¨rker’s cell-counting cham-
ber. Experiments were performed in triplicate.
Identification of differentially expressed genes
The mRNA Differentially Display PCR (DD-PCR) procedure used
was essentially identical to van Belzen et al. (23). In short, LNCaP-1F5
cells were cultured in maintenance medium until 50–60% confluence
and for an additional 72 h in RPMI 1640 supplemented with 5% dcc
serum. After this period, the medium was replaced by RPMI medium
containing 5% dcc serum supplemented with 1 nm R1881, or 10 nm Dex,
or without hormone, and cells were incubated for an additional 24 h.
Isolation of total cellular RNA from the different cell lines was carried
out according to Chirgwin et al. (22). First-strand cDNA was synthesized
from 1 mg total RNA with M-MuLV RT and a mix of three anchored
oligo-T primers: 59-TTTTTTTTTTTTG-39, 59-TTTTTTTTTTTTC-39, and
59-TTTTTTTTTTTTA-39. The resulting cDNAs from RNA of LNCaP cells
grown under the three different growth conditions were amplified for
two cycles at low stringency annealing conditions (1 min at 94 C, 5 min
at 35 C, 5 min of gradual heating from 35 C to 72 C, and 5 min at 72 C),
followed by 30 cycles at high stringency annealing (1 min at 94 C, 2 min
at 50 C, and 2 min at 72 C) using a 15- to 25-nucleotide arbitrary primer.
All reactions were performed in triplicate. The resulting PCR products
were separated on a 7.5% polyacrylamide gel containing 7 m urea. The
dried gel was exposed to x-ray film. Bands of interest were eluted from
gel by incubation for 1 h at 65 C in TE (10 mm Tris-HCl, pH 7.4; 1 mm
EDTA). Subsequently, the eluted fragments were amplified by an ad-
ditional PCR step (30 cycles: 1 min at 94 C, 2 min at 50 C, and 2 min at
72 C). The amplified cDNAs were cloned in pGEM-T (Promega, Mad-
ison, WI), and sequenced.
Results
Generation of GR-expressing LNCaP transfectants
LNCaP cells were transfected with the available rat GR
expression vector PSTC-GR and the pSV2Neo selection plas-
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mid. Because of the high structural homology between the rat
and human GR, human GR is expected to give identical
results. Cells were grown in medium supplemented with
G418 to select for transfected cells. After 3 weeks, G418-
resistant clones were selected. Clones were immunohisto-
chemically stained with the GR antibody MAb 7. Of 60 G418-
resistant clones, five showed strong reactivity with the
antibody, indicating high GR expression. Thirty-two clones
showed low or heterogeneous GR expression, whereas in the
remaining clones, no GR immunoreactivity was observed.
Staining of two clones with high levels of GR expression
(LNCaP-1B7 and LNCaP-1F5) is shown in Fig. 1, A and B;
staining of the parental LNCaP cells for GR was negative
(Fig. 1C). Note that the morphology of GR1 sublines is
different from that of the parental cells, indicating a thus far
unexplained specific effect of the activated GR on cell phys-
iology. LNCaP-1B7 and LNCaP-1F5 were selected for more
detailed studies.
Characterization of LNCaP-1B7 and LNCaP-1F5
Southern blot analysis of EcoRI-digested genomic DNA
isolated from the LNCaP-1B7 and LNCaP-1F5 transfectants
demonstrated the presence of one or more copies of the
complete CMV-GR cDNA fragment in both clones (lanes 2
and 3, Fig. 2A; indicated by an arrow). The rat GR probe
showed cross-hybridization to two fragments corresponding
to the endogenous human GR gene (bands a and b; see also
lane 1, containing parental LNCaP DNA). Both LNCaP-1B7
and LNCaP-1F5 DNA contained also at least one incomplete
PSTC-GR fragment (bands c and d). Densitometric scanning
of the blot revealed the presence of 6 to 7, and two complete
copies of CMV-GR cDNA in LNCaP-1B7 and LNCaP-1F5,
respectively.
Northern blot analysis of LNCaP-1B7 and LNCaP-1F5
RNA showed expression of GR mRNA of the expected size
(2.7 kb) in both clones; no hybridization signal was observed
in the parental LNCaP cell line (Fig. 2B). The presence of
more GR mRNA in LNCaP-1F5 as compared with LNCaP-
1B7 cells, despite the higher number of integrated GR cDNA
copies in LNCaP-1B7 cells, can be due to different genomic
integration sites. Radioligand-binding assays on LNCaP,
LNCaP-1B7, and LNCaP-1F5 cells were performed to estab-
lish the number of GR and AR molecules per cell and the
respective dissociation constants for both receptors (Fig. 3).
The parental LNCaP cell line showed for R1881 a Bmax of
75 pm, which is equivalent to approximately 15,000 AR mol-
ecules per cell (see legend to Fig. 3). LNCaP-1B7 and LNCaP-
1F5 contained approximately 30,000 and 32,000 AR mole-
cules per cell, respectively. This 2-fold higher level of AR in
the newly generated cell lines in comparison to the parental
LNCaP is probably due to a small variation in AR content in
the parental LNCaP cells. All three cell lines showed an
identical binding affinity for R1881 (Kd 1.1 nm).
As expected, in the parental LNCaP cell line, binding of
Dex could not be detected. From the Bmax values it could be
deduced that LNCaP-1B7 contains approximately 31,000 GR
copies per cell, and LNCaP-1F5 contains 115,000 copies. The
Kd for Dex binding was 3.1 nm in both LNCaP sublines.
In the four lower panels of Fig. 3, the values obtained at the
two highest ligand concentrations deviate from the calcu-
lated straight line. The apparent curvilinearity of the Scat-
chard data are most likely due to the low percentage of
specific binding at high ligand concentrations, which makes
these data less reliable. The program used for Scatchard and
linear regression analyses took the differences in specific
binding into account. An alternative explanation, interaction
between GR and AR, is less likely, because experiments were
done in the presence of one hormone at a time (or R1881 or
Dex).
GR activity in GR-positive LNCaP sublines
To investigate whether the GR present in LNCaP-1B7 and
LNCaP-1F5 cells was functionally active, the cells were tran-
siently transfected with PSA-61-LUC, which contains a 6-kb
PSA promoter fragment. This promoter contains a strong
androgen-dependent enhancer region, approximately 4.2 kb
upstream of the transcription start site of the PSA gene (17,
24). As expected, PSA-61-LUC showed clear, R1881-induced
FIG. 1. Immunohistochemical staining of GR-positive LNCaP sublines LNCaP-1B7 (A), LNCaP-1F5 (B), and the parental LNCaP cells (C) with
the anti-rat-GR monoclonal antibody Mab7, using the indirect PAP technique (magnification 200 3). Cells were counterstained with Mayer’s
hematoxylin. Before immunohistochemical analysis, cells were cultured for 24 h in the presence of Dex.
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luciferase activity in transfected parental LNCaP cells. No
luciferase activity was detected upon incubation of the PSA-
61-LUC-transfected parental LNCaP cells with Dex (Fig. 4).
Transient transfection of LNCaP-1B7 and LNCaP-1F5 cells
with the PSA-61-LUC construct resulted in a comparable
R1881-induced luciferase activity, both in absolute luciferase
activity and in induction level (1310- and 1940-fold, respec-
tively). Dex induced a slightly higher PSA-61-LUC activity,
clearly indicating the transactivating capacity of the GR en-
coded by the stably integrated rGR expression vector (Fig. 4).
Regulation of endogenous PSA mRNA expression
In previous studies we and others (12–14) have shown that
PSA mRNA expression is induced upon androgen incuba-
tion of LNCaP cells. To investigate whether GR can replace
AR in induction of the endogenous PSA gene, we performed
Northern blot analysis with RNAs isolated from the parental
LNCaP cell line, and from LNCaP-1B7 and LNCaP-1F5 cells,
grown in the absence and in the presence of hormone (10 nm
Dex or 1 nm R1881). Hybridization with a PSA-specific cDNA
probe demonstrated that GR can replace AR in high, steroid
hormone-induced expression of the PSA gene (Fig. 5). In the
parental LNCaP cell line, PSA mRNA expression was in-
duced by R1881 but not by Dex. In contrast, in the two
GR-positive clones, Dex treatment clearly resulted in stim-
ulation of PSA mRNA expression, although to a slightly
lower level (approximately 3-fold) than R1881 up-regulated
PSA mRNA.
Regulation of cell proliferation
Growth of LNCaP cells depends on androgens in a con-
centration-dependent fashion. Previous studies indicated a
bell-shaped dose-response curve for the stimulatory effect of
androgens (11). Maximal growth stimulation of R1881 was
observed at a concentration of 0.1 nm. To find out whether
GR was able to replace AR in growth regulation of LNCaP
cells, we compared the effects of different R1881 and Dex
concentrations on growth of LNCaP cells and of the two
GR-positive LNCaP sublines. At day 8 after addition of hor-
mone, all three cell lines showed a clear growth stimulation
upon treatment with 0.1 nm R1881 and to a somewhat lower
extent at 1 nm R1881. However, at none of the tested Dex
concentrations was a growth-stimulatory effect observed
(Fig. 6). Similar negative results were obtained with hydro-
cortisone (data not shown). These results clearly indicated
that GR was unable to replace AR in growth stimulation of
LNCaP cells.
Detection of androgen-specific gene expression in LNCaP-
1F5 cells
Using the DD-PCR method, a search for novel, differen-
tially expressed genes in the LNCaP-1F5 subline, grown in
the presence of R1881, or Dex, or in the absence of hormone,
was initiated. Using 35 different arbitrary PCR primers, one
fragment that was differentially expressed was detected. The
fragment, designated 21.1, was amplified from RNA of
LNCaP-1F5 cells, cultured in the presence of R1881 (arrow in
Fig. 7A), and not from RNA of Dex- incubated LNCaP-1F5
cells, or cells incubated in the absence of hormone. Using
fragment 21.1 as a hybridization probe, on a Northern blot
of LNCaP-1F5 RNA, a mRNA of approximately 5 kb was
detected, and the differential expression pattern was con-
firmed (Fig. 7B). The sequence of the 504-bp 21.1 fragment is
available in GenBank under accession number AF007835.
FIG. 2. Southern and Northern blot
analysis of the integrated GR cDNA (A),
and GR mRNA expression (B) in GR1
LNCaP sublines and parental LNCaP
cells. A, Southern blot analysis of
EcoRI-digested genomic DNA from
LNCaP (lane 1), LNCaP-1B7 (lane 2),
and LNCaP-1F5 (lane 3). DNA (10 mg/
lane) was hybridized with a rat GR
cDNA probe, homologous to human GR
cDNA. Bands a and b, Endogenous hu-
man GR gene; bands c and d, inte-
grated, partial rGR cDNA fragments.
The arrow indicates the position of in-
tegrated, complete CMV-GR cDNA cop-
ies. B, Northern blot analysis of 10 mg
total RNA from LNCaP (lane 1), LN-
CaP-1B7 (lane 2), and LNCaP-1F5
(lane 3) hybridized with a rat GR cDNA
probe. The lower panel shows b-actin
mRNA expression.
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Discussion
In this paper we describe the generation and properties of
LNCaP sublines that express not only AR but also GR. These
novel cell lines facilitate the direct comparison of GR and AR
effects on cellular functioning. Furthermore, they can be em-
ployed for investigation of interference between GR- and
AR-activated molecular and biological processes. We dem-
onstrated that AR- and GR-positive cells behave identically
in up-regulation of the expression of a transfected PSA pro-
moter-driven reporter gene, and the expression of the en-
dogenous PSA gene. Interestingly, they were found to differ
in hormone- induced effects on cell proliferation. Addition-
ally, one novel, differentially expressed gene was identified.
At least part of the effects of steroid hormone receptors on
FIG. 3. Analysis of glucocorticoid- and androgen-binding activity in parental LNCaP and the GR transfectant 1B7 and 1F5 cells. Scatchard
representation of R1881-binding activity (panel A) and Dex-binding activity (panel B) of LNCaP, LNCaP-1B7, and LNCaP-1F5 cells. Cellular
AR and GR concentrations were deduced from (Bmax (M) 3 Nav)/number of cells per liter (3 3 10
9 in panel A and 5 3 109 in panel B).
Receptor-bound 3H-labeled steroid was measured by a whole cell assay in the presence and absence of a 100-fold molar excess of unlabeled
hormone. The values shown are the mean of a triplicate experiment and represent specific binding after subtraction of nonspecific binding.
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gene expression is on transcription initiation. Upon ligand
binding, steroid receptors interact with specific DNA se-
quences (HREs) and regulate the transcription of target
genes. The GGT/AACAnnnTGTTCT consensus sequence
for high-affinity DNA binding of GR, MR, PR, and AR is
identical (5–8). Despite this common DNA-binding site, the
different receptors mediate distinct cellular responses. Many
independent mechanisms to achieve specificity of the steroid
hormone response have been proposed (see for reviews Refs.
3 and 25). These include differential affinities to natural re-
ceptor-binding sites, or to binding sites in their natural DNA
context (26–30), differential affinity to general and specific
transcription factors (31–34), differences in interaction with
receptor-specific accessory proteins or coactivators (35–37),
differential modification of specific chromatin structures (38,
39), differences in cellular concentration of the specific re-
ceptors (40), and variations in ligand availability (41, 42).
The observation that PSA mRNA was Dex inducible in the
GR-expressing LNCaP sublines showed that the steroid re-
ceptor content determines, at least in part, the specific acti-
vation of the PSA gene in wild-type LNCaP cells. Transient
transfection of the 6-kb PSA promoter to the LNCaP sublines
resulted also in activation by both AR and GR. In contrast,
in the case of the MMTV promoter, differences have been
reported on the effect of GR and PR on transiently transfected
reporter gene constructs and stably integrated plasmids (38,
FIG. 4. R1881 and Dex regulation of the PSA promoter activity in
LNCaP and GR- positive LNCaP sublines. LNCaP, LNCaP-1B7, and
LNCaP-1F5 cells were transfected with the PSA-61-LUC reporter
gene construct as described in Materials and Methods. After overnight
incubation with the precipitate, cells were incubated for 24 h either
in the presence or absence of 1 nM R1881 or 10 nM Dex. Activity in the
absence of hormone is indicated by a solid bar; activity in the presence
of R1881 is shown by a hatched bar and in the presence of Dex by a
gray bar. Fold-induction is displayed on top of the bars. The absolute
activity and relative induction factor were calculated as the mean of
three independent transfection experiments, which were all done in
duplicate. The SE of the mean (SEM) of the absolute activity is repre-
sented by a vertical stripe; the SEM of induction is given in parentheses.
FIG. 5. Expression of the rat GR renders the endogenous androgen-
regulated PSA gene inducible by Dex in the LNCaP sublines 1F5 and
1B7. Northern blot analysis of 10 mg total RNA of LNCaP-1F5 (lanes
1–3), LNCaP-1B7 (lanes 4–6), and LNCaP (lanes 7–9) cells hybrid-
ized with a PSA cDNA probe. Cells were treated for 24 h with 10 nM
Dex (lanes 3, 6, and 9), 1 nM R1881 (lanes 2, 5, and 8), or were grown
in the absence of hormone (lanes 1, 4, and 7). The lower panel shows
hybridization of the b-actin cDNA probe as a control.
FIG. 6. Effects of Dex and R1881 on cell growth of parental LNCaP,
and the GR1 1B7 and 1F5 cells. At day 0, and at day 8 of incubation
in the absence or presence of hormone, cells were washed, trypsinized,
and counted. The values shown are the mean of experiments in trip-
licate; the SEM is represented by a vertical stripe. *, P , 0.05 compared
with cells grown in the absence of hormone, or in the presence of
different Dex concentrations.
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39). It appears that the native chromatin structure can pre-
vent PR activation and permits GR stimulation of the stably
integrated target gene.
AR activation of the PSA promoter involves at least three
androgen response elements, two in the 600-bp proximal
promoter region and one in a far upstream enhancer region
(17, 43). Although ultimate PSA promoter induction is com-
parable for AR and GR, it cannot be excluded as yet, that AR
and GR affect the individual regulatory regions differen-
tially. Such an observation has been made for GR and PR
activation of the MMTV promoter, which contains four
HREs. Differences might be accounted for by distinct chro-
matin structures over the individual HREs, and the ability of
the different receptors to affect these structures, and/or the
interaction with other specific transcription factors (34).
As shown above, in contrast to normal human prostate
tissue, GR expression cannot be detected in wild type LNCaP
cells (44). However, in normal prostate highest GR expres-
sion is in the stromal compartment. In epithelial cells ex-
pression of AR appears much higher than GR expression. In
prostate cancer, GR expression seems even to decrease.
Therefore, GR might not be a major factor in PSA expression.
No data are available relating to PR expression in prostate
tissue, another candidate for regulation of PSA expression
(17).
The stimulatory effect of androgens on LNCaP cell pro-
liferation shows a bell-shaped dose-response curve (11, 45).
At low androgen concentrations (up to 10210 m R1881),
LNCaP cells proliferate in a dose-dependent manner; at
higher hormone concentration, the proliferation rate is less.
The molecular mechanism of growth stimulation by andro-
gens, including the remarkable dose response, is not fully
understood, although it has been proposed that TGFb1 me-
diates at least part of the growth arrest observed at high
androgen concentration (46). The cell growth studies clearly
demonstrated that Dex was unable to induce proliferation of
LNCaP-1B7 and LNCaP-1F5 cells. The molecular mechanism
responsible for the differential effects of glucocorticoids and
androgens on growth remains to be investigated. In a prob-
ably oversimplified view it can be hypothesized that a lim-
ited number of differentially expressed genes are involved.
Differential AR and GR regulated TGFb and other growth
factors or inhibitors, and their corresponding receptors
should be considered in this regard.
The novel clone 21.1 described here might be another
candidate involved in a specific AR function in LNCaP. Iso-
lation and characterization of full-length 21.1 cDNA and the
accompanying gene, which might provide information on
21.1 function and regulation of expression, are in progress.
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